Changzhou Qianhong Biopharma Co Ltd Class A 002550
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 5.96
- Day Range
- CNY 5.86–5.98
- 52-Week Range
- CNY 4.20–6.34
- Bid/Ask
- CNY 5.90 / CNY 5.91
- Market Cap
- CNY 7.55 Bil
- Volume/Avg
- 15.0 Mil / 12.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 47.05
- Price/Sales
- 4.48
- Dividend Yield (Trailing)
- 2.03%
- Dividend Yield (Forward)
- 2.03%
- Total Yield
- 2.03%
Company Profile
Changzhou Qianhong Biopharma Co Ltd engages in the research and development, production, and sale of biopharmaceutical products with the focus on polysaccharides and enzymes in China. The company provides various products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; and kallidinogenase kallikrein and heparinoid.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,067
- Website
- http://www.qhsh.com.cn
Comparables
Valuation
|
Metric
|
002550
|
300239
|
300255
|
|---|---|---|---|
Price/Earnings (Normalized) | 47.05 | 33.72 | — |
Price/Book Value | 3.06 | 1.97 | 5.93 |
Price/Sales | 4.48 | 3.66 | 8.61 |
Price/Cash Flow | 10.19 | 16.48 | 41.87 |
Price/Earnings
002550
300239
300255
Financial Strength
|
Metric
|
002550
|
300239
|
300255
|
|---|---|---|---|
Quick Ratio | 5.14 | 3.59 | 0.33 |
Current Ratio | 7.58 | 4.57 | 1.19 |
Interest Coverage | 41.90 | 24.27 | −13.09 |
Quick Ratio
002550
300239
300255
Profitability
|
Metric
|
002550
|
300239
|
300255
|
|---|---|---|---|
Return on Assets (Normalized) | 5.62% | 4.57% | −24.73% |
Return on Equity (Normalized) | 6.52% | 6.89% | −53.95% |
Return on Invested Capital (Normalized) | 5.86% | 5.42% | −25.87% |
Return on Assets
002550
300239
300255
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Rknkjgsks | Cghy | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Frshgkhs | Jzchr | $74.3 Bil | |
HLN
| Haleon PLC ADR | Fgrxnqd | Vxw | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Xxxjnqqcb | Xfttp | $18.3 Bil | |
VTRS
| Viatris Inc | Ywknhgm | Sjnw | $13.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Spntyrvdb | Lscv | $11.7 Bil | |
CTLT
| Catalent Inc | Brdrjvrk | Vmqrcr | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Hfvclrjbq | Plsm | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Zmwyyjd | Cqz | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Nlchmbdy | Ygnvlf | $3.5 Bil |